Clinical Trial Update: A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SHR-2017 Injection for prevention of bone events in patients with bone metastases from solid tumors; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• SHR-2017 Injection (SHR-2017)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors | Phase 2 | Status: RECRUITING